Over Twenty-five Institutions Worldwide are Participating in the PARSC Clinical Trial for Early Stage Colon Cancer

United States

Principal Investigator: Ken Deck, MD
South Orange County Surgical Medical Group
Laguna Hills, California

Principal Investigator: Imad Shbeeb, MD
Long Beach Memorial Medical Center
Long Beach, California

Principal Investigator: Steven Chen, MD
University of California, Davis Cancer Center
Sacramento, California

Principal Investigator: John L Marshall, MD
Lombardi Cancer Center
Georgetown University Hospital
Washington, District of Columbia

Principle Investigator: Sanjay Goel, MD
Montefiori Medical Center
Bronx, New York City, New York

Principal Investigator: Edward Levine, MD
Wake Forest University
Winston-Salem, North Carolina

Principal Investigator: Gordon Klatt, MD
Franciscan Research Center
Tacoma, Washington

Principal Investigator: Michael Knauer, MD
Landeskrankenhaus Feldkirch
Feldkirch, Austria

Principal Investigator: Rupert Bartsch, MD
Krankenhaus der Elisabethinen
Linz, Austria

Principal Investigator: Thomas Bachleitner-Hofmann, MD
Medical University of Vienna
Vienna, Austria

Principal Investigator: Wai Lun Law, MD
University of Hong Kong/ Queen Mary Hospital
Hong Kong, China

Principal Investigator: Tine Plato Hansen, MD
Odense Universitetshospital
Odense, Denmark

Principal Investigator: Frederic Bibeau, MD
CRLC Val d'Aurelle-Paul Lamarque
Montpellier, France

Principal Investigator: Robert Rosenberg, MD
Klinikum Rechts Der Isar
Munich, Germany

Principal Investigator: Michio Asano, MD
Matsuda Hospital
Hamamatsu, Japan

Principal Investigator: Toshiaki Watanabe, MD
Teikyo University School of Medicine
Tokyo, Japan

Principal Investigator: Koos van der Hoeven, MD
Medisch Centrum Alkmaar
Alkmaar, Netherlands

Principal Investigator: Martijn Lutke Holzik, MD
Medisch Spectrum Twente
Enschede, Netherlands

Principal Investigator: Jan Willem de Waard, MD
Westfriesgasthuis
Hoorn, Netherlands

Principal Investigator: Rob Tollenaar, MD
Leids Universitair Medisch Centrum
Leiden, Netherlands

Principal Investigator: Josep Tabernero, MD
Vall d' Hebron University Hospital
Barcelona, Spain

Principal Investigator: Ramon Salazar, MD
IDIBELL Institut Catala d'Oncologia (ICO)
L'Hospitalet de Llobregat, Spain

Principal Investigator: Jan-Erik Frodin, MD
Karolinska University Hospital
Stockholm, Sweden

Principal Investigator: Bengt Glimelius, MD
Immunology Akademiska sjukhuset/ University Hospital
Uppsala, Sweden

Principal Investigator: James Sington, MD
Norfolk and Norwich University Hospital
Norwich, United Kingdom

Principal Investigator: David Kerr, MD
University of Oxford
Oxford, United Kingdom

For additional information on Agendia’s PARSC clinical trial please visit ClinicalTrials.Gov: Colon Cancer Clinical Trial

For more information on participation in Agendia's PARSC clinical trial, please contact Agendia Clinical Trials.